NasdaqCM:DRTSMedical Equipment
Alpha Tau Medical (DRTS) Reaches ADMIRE Milestone, Is The Stock Now Fully Valued?
ADMIRE Milestone and Why It Matters for Alpha Tau Medical Stock
Alpha Tau Medical (NasdaqCM:DRTS) drew fresh attention after reporting the first successful treatment of an immunocompromised patient in its ADMIRE clinical study for recurrent cutaneous squamous cell carcinoma using Alpha DaRT.
This marks a key clinical milestone for a vulnerable cancer population that often has limited treatment options, giving investors new information to weigh around the company’s technology focus and...